Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
12,210,000
-
Number of holders
-
54
-
Total 13F shares, excl. options
-
8,065,328
-
Shares change
-
+631,360
-
Total reported value, excl. options
-
$144,178,979
-
Value change
-
+$11,388,677
-
Number of buys
-
34
-
Number of sells
-
10
-
Price
-
$17.95
Institutional Holders of Q32 Bio Inc. - Common stock, par value $0.0001 per share (QTTB) as of Q2 2024
As of 30 Jun 2024 Q32 Bio Inc. - Common stock, par value $0.0001 per share (QTTB) had 54 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 8,065,328 shares of stock of the company.
Largest 10 holders included ORBIMED ADVISORS LLC, Atlas Venture Life Science Advisors, LLC, Carlyle Group Inc., BlackRock Inc., ARCH Venture Management, LLC, Temasek Holdings (Private) Ltd, 5AM Venture Management, LLC, FMR LLC, HARVARD MANAGEMENT CO INC, and ADAR1 Capital Management, LLC.
This table shows 54 institutional shareholders of the security as of 30 Jun 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.